PreveCeutical Medical (TSE:PREV) has released an update.
PreveCeutical Medical Inc., facing a delay due to financial constraints, has been issued a Management Cease Trade Order after failing to file its annual financial statements and related documents by the required deadline. They expect to complete the filings by June 28, 2024, and will keep the markets updated in accordance with regulatory guidelines. Trading in the company’s shares by the general public remains unaffected, although insiders are restricted from trading until compliance is restored.
For further insights into TSE:PREV stock, check out TipRanks’ Stock Analysis page.
